We developed an interactive and menu-driven computer program to help investigators design and analyze phase II cancer clinical trials with a group sequential method, namely the sequential probability ratio test or the triangular test. Based on the values selected for the parameters of the trial, the
A computer program for the design and the analysis of phase II cancer clinical trials with the triangular test
โ Scribed by Eric Bellissant; Jacques Benichou; Claude Chastang
- Book ID
- 113297455
- Publisher
- Elsevier Science
- Year
- 1991
- Tongue
- English
- Weight
- 81 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0197-2456
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Clinical scientists are becoming increasingly aware of the need to monitor clinical trials in progress, and to validate their procedure by the use of a formal sequential design. An interactive program, written in FORTRAN 77 and called "PEST: Planning and Evaluation of Sequential Tests," is introduce
Phase I Clinical Trials in children with cancer are carried out with therapeutic intent, so as to define antileukemic/antitumor activity, dose-limiting toxicity, maximum tolerated dosage, and pharmacokinetics. These studies define a dosage of an agent or combination that may be used in a larger stud
We consider a clinical trial model comparing an experimental treatment with a control treatment when the responses are binary. For fixed significance level and power, we compare the expected number of treatment failures for two designsthe randomized play-the-winner rule and the triangular test. The